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Abstract
The repair process after CNS injury shows a well-organized cascade of three distinct stages: inflammation, new tissue
formation, and remodeling. In the new tissue formation stage, various cells migrate and form the fibrotic scar surrounding
the lesion site. The fibrotic scar is known as an obstacle for axonal regeneration in the remodeling stage. However, the role
of the fibrotic scar in the new tissue formation stage remains largely unknown. We found that the number of A-kinase
anchoring protein 12 (AKAP12)-positive cells in the fibrotic scar was increased over time, and the cells formed a structure
which traps various immune cells. Furthermore, the AKAP12-positive cells strongly express junction proteins which enable
the structure to function as a physical barrier. In in vivo validation, AKAP12 knock-out (KO) mice showed leakage from a
lesion, resulting from an impaired structure with the loss of the junction complex. Consistently, focal brain injury in the
AKAP12 KO mice led to extended inflammation and more severe tissue damage compared to the wild type (WT) mice.
Accordingly, our results suggest that AKAP12-positive cells in the fibrotic scar may restrict excessive inflammation,
demonstrating certain mechanisms that could underlie the beneficial actions of the fibrotic scar in the new tissue formation
stage during the CNS repair process.
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Introduction
In most organ systems, the response to injury can be commonly
classified into three distinct stages: inflammation, new tissue
formation, and remodeling [1]. The CNS repair process also
shows a well-organized cascade of three distinct stages [2].
Inflammation occurs immediately after CNS injuries. Numerous
blood-born immune cells infiltrate into the lesion and resident
microglia cells are also activated [3]. Such an innate immune
system prevents additional infections and regulates the phagocy-
tosis of damaged tissue [4]. In next stage, new tissue formation
occurs from days to weeks after injury. Activated proliferating cells
derived from various origins migrate to the lesion site and produce
chondroitin sulfate proteoglycans (CSPGs) and extracellular
matrixes (ECMs), resulting in the formation of the CNS scar
which consists of two distinct layers, the fibrotic scar and the glial
scar. The fibrotic scar directly surrounds the lesion site and the
glial scar forms the boundary between the fibrotic scar and the
normal parenchymal tissues [5,6]. Lastly, the remodeling stage
starts about 3 weeks after injury and can be maintained for several
months depending on injury. During this stage, newly formed
tissues are stabilized and axonal circuits are reconstructed by
axonal regeneration [7].
Because the fibrotic scar is the main resource of CSPGs and
ECMs which inhibit axonal regeneration, it has been recognized
as an obstacle for axonal regeneration during the remodeling
stage. Therefore, previous studies on the fibrotic scar mainly
focused on blocking the harmful function of the remodeling stage
with its inhibition of axonal regeneration [8,9]. However, the role
of the fibrotic scar in the new tissue formation stage remains
largely undefined. Recently, it has been identified by several
studies that the fibrotic scar is a complex structure composed of
various cells which have different properties and origins like
meningeal cells and pericytes [5,10], implying that the fibrotic scar
could be multi-functional. Therefore, the roles of fibrotic scar need
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to be investigated in the new tissue formation stage of the CNS
repair process.
AKAP12 is known as a tumor suppressor protein reduced in the
metastatic progression of human prostate cancer [11], and loss of
the AKAP12 gene induced prostatic hyperplasia in mice [12].
Furthermore, an in vitro study showed that the suppression of
AKAP12 increases cell motility and invasion [13]. In zebrafish
development, AKAP12 regulates the movement of mesodermal
cells. AKAP12 morphant embryos exhibited severe extension
defects, resulting from the unregulated protrusive activity of
paraxial mesodermal cells [14]. Because AKAP12 is crucial for cell
motility and stability, which are closely related to scar formation
and it is the multifunctional scaffolding protein which serves as a
platform for various signals, it is an attractive candidate molecule
that integrates scar formation as a result of complex events such as
the immune response, migration of various cells, and tissue
remodeling.
Here, we show that AKAP12-positive cells participate in
formation of the fibrotic scar and that the cells mediate the
beneficial role of the fibrotic scar as a barrier through the structure
which physically segregates immune cells during the new tissue
formation stage of CNS repair. Together with the data of previous
studies [8], our findings suggest that the fibrotic scar could have
different functions depending on the stage of repair following CNS
injury, providing an extended and more nuanced view of the
fibrotic scar in CNS injuries.
Materials and Methods
1. Animals
C57BL/6 (Orient Bio Inc., Seongnam, Korea) were used for
observations at the serial time points. Breeding colonies of WT
and AKAP12 KO mice (C57BL/6 background) [12] were
established and used for comparison experiments. All mice were
maintained in a SPF room in the animal-housing facilities at the
Seoul National University. Animal experiments were approved by
the Committee for Care and Use of Laboratory Animals at the
Seoul National University, according to the Guide for Animal
Experiments edited by the Korean Academy for Medical Sciences.
2. Photothrombosis & MCAO
WT and AKAP12 KO mice (C57BL/6 background, male,
weighing 23–25 g) were subjected to photothrombosis [15]. Under
anesthesia by intraperitoneal injection of Zoletil (30 mg/kg) and
Rompun (10 mg/kg), Rose Bengal (Sigma, 0.1 ml/25 g body
weight of 10% solution) was injected via the tail vein, which was
allowed to circulate for 5 min. After an incision in the scalp was
made, the skull was exposed to a cold light source (Zeiss FL1500
LCD, 150W, 1 mm diameter) for 20 min. The position of the
optic center was 2.5 mm to the left and 2.5 mm to the back of the
bregma. The scalp was sutured and the mice were allowed to
regain consciousness.
Male Wistar rats, weighing 280–310 g, were subjected to
MCAO/R using the modified method of the intraluminal nylon
suture technique [16,17]. Briefly, under a surgical microscope and
general anesthesia, the left common carotid artery (CCA) was
exposed via a ventral midline incision. The CCA, external carotid
artery (ECA) and pterygopalatine artery were ligated with 5-0
black silk. A 4-0 monofilament nylon (Doccol Corp.) was advanced
approximately 23 mm from the ICA origin into the MCA.
Reperfusion was achieved by pulling on the suture until resistance
was felt.
3. Immunofluorescence
Anesthetized mice were perfused with 0.1 M PBS (pH 7.4).
Isolated brains were fixed with 4% PFA at 4uC and dehydrated
with serial gradients of sucrose. Cryostat sections of 10 mm were
attached on the gelation coated slide and 30 mm sections were
stored in the preservation solution for floating staining. The
samples were stained with primary antibodies against AKAP12 (I.
Gelman, Roswell Park Cancer Institute), E-cadherin, CD31,
CD45 (BD), GFAP, fibronectin, MPO (DAKO), GS-lectin,
Occludin, ZO-1 (Invitrogen) and IBA1 (WAKO) overnight at
4uC followed by Alexa 488, 546 and 350 (Invitrogen) secondary
antibodies at RT for 1 h. Nuclear-staining was performed with
Hoechst 33342 (Molecular Probes). Images were obtained with an
ApoTome microscope (Carl Zeiss, Axiovert M200) or confocal
microscopy (Carl Zeiss, LSM700).
4. Evans blue permeability assay
Four mice per WT and KO at each time point were used for
comparison. Under anesthesia with 4% isoflurane, Evans blue
solution (Sigma, 2% in saline; 4 mL/kg) was injected via the tail
vein. After circulation for 2 h, brains were extracted and dissected
into hemispheres. Each hemisphere was homogenized (Tissue
Tearor, 50 s; speed 35) in 1 mL (total volume) of 0.1 M PBS. The
supernatant was collected and mixed with trichloroacetic acid
solution (Sigma, 50% in saline). After centrifugal precipitation, the
supernatant was extracted and the absorbance was measured at
610 nm with a spectrophotometer.
5. Luxol Fast Blue (LFB) staining & Triphenyltetrazolium
chloride (TTC) staining
Four mice per WT and KO group were used for comparison.
Six representative sections were selected at the lesion site 540 mm
in diameter and stained with LFB solution (Sigma). Serial brain
slices (1 mm thickness) near the lesion site were incubated for
30 min at 37uC in 0.05% TTC (Sigma) solution. After washing in
PBS, stained slices were fixed in 4% PFA for 30 min. The ratio of
the LFB (2) region and TTC (2) region to the total brain was
analyzed with image analysis software (NIH-Image J).
6. Western blotting
The lesion tissues from four mice per group were homogenized
and lysed in buffer [20 mM Tris-HCl (pH 7.5), 150 mM NaCl,
1 mM Na2EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium
pyrophosphate, 1 mM beta-glycerophosphate, 1 mM Na3VO4,
1 mg/ml leupeptin, and protease inhibitor cocktail]. Western blot
analysis was performed as described previously [18]. Immuno-
blotting was performed using primary antibodies against AKAP12
(Santa Cruz, I. Gelman, Roswell Park Cancer Institute), a-tubulin
(InnoGenex), E-cadherin (BD), ZO-1 and Occludin (Invitrogen).
7. Genomic PCR
Genomic PCR analysis was performed as described previously
[12]. Sequences for the primers used are as follows. WT allele (F)
59-CGC TGT ACT ACT AAG GAG AGT GTT ACG-39 and
(R) 59-CCT CCT GGG TCT CAG CCA GTT TCT CAG
GGG-39, KO allele: (F) 59-CGG CTG GGT GTG GCG GAC
CGC TAT CAG GAC ATA GCG-39 and (R) 59-CTC AGC
CTT TGC CAG AAT AGG CAC TGC CCC-39
8. Data analysis and statistics
Quantification of the band intensities was analyzed with Image J
and normalized to the density of GAPDH and a-tubulin.
Statistical analysis was done with an unpaired two-tailed Student
AKAP12 (+) Cells Mediate the Fibrotic Scar Barrier
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t-test for single comparisons and ANOVA followed by post hoc
analysis with Tukey-Kramer test for multiple comparisons. P,
0.05 was considered statistically significant.
Results
AKAP12 is highly expressed in the fibrotic scar
surrounding the lesion during CNS repair process
To identify the role of AKAP12 in the repair process after CNS
injury, we sampled mice brains at serial time points after focal
brain injury induced by photothrombosis, and examined the
AKAP12 level during CNS repair. Immumnostaining data shows
that AKAP12 was highly expressed in the normal meninges
(Fig. 1A_Control) and the number of AKAP12-positive cells
increased around the lesion tissue remarkably over time (Fig. 1A
and B). Finally, AKAP12-positive cells formed the distinct layer
bound to the lesion core (Fig. 1A_PT 14 and PT21).
Similar to previous studies [19,20], we observed that photo-
thrombotic injury also induced the formation of the CNS scar
which consists of two distinct layers, the fibrotic scar (fibronectin-
positive) and the glial scar (GFAP-positive) surrounding the lesion
site (Fig. 1C largest panel) and that AKAP12-positive cells were
Figure 1. AKAP12 is highly expressed in the fibrotic scar surrounding the lesion in the process of CNS repair. (A) Brain sections were
stained with antibody against AKAP12. AKAP12 was highly expressed in the normal meninges, and the number of AKAP12-positive cells in the scar
tissue increased over time. Yellow boxes were magnified in right panels. Scale bar: 500 mm (large panels), 50 mm (magnified panels) (B) The AKAP12-
positive area of three representative sections per mouse was analyzed using Image J. (Mean6 S.D.; n = 4 mice per each time; P*,0.05, P#,0.001) (C)
Mouse brains were harvested at 21 days after photothrombotic injury. Brain sections were stained with antibody against AKAP12, GFAP (a marker for
the glial scar) and fibronectin (a marker for the fibrotic scar). Yellow box was magnified in lower panels. Scale bar: 500 mm (largest panel), 200 mm
(magnified panels) (D) AKAP12 gene KO was confirmed through genomic PCR and tissue western blotting. PCR analysis of mouse brain DNA showing
the AKAP12 WT and KO alleles in the WT or AKAP12 KO mice and immunoblotting analysis of the brain lysates from the WT and KO mice using two
different AKAP12 antibodies. (E) Mouse brains were harvested at 21 days after photothrombotic injury. The specificity of the AKAP12 signal was
supported by lack of AKAP12 staining in the fibrotic scar in the AKAP12 KO mice. Scale bar: 200 um [LC: lesion core, FS: fibrotic scar, GS: glial scar].
doi:10.1371/journal.pone.0094695.g001
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primarily located in the fibrotic scar tissue (Fig. 1C magnified
panels). For the in vivo validation of the role of AKAP12-positive
cells in the fibrotic scar, we introduced the AKAP12 KO mice
system [12]. Prior to the in vivo validation, the knock-out of the
AKAP12 gene was confirmed by comparing the brain tissues of
WT and AKAP12 KO mice using genomic PCR and western
blotting (Fig. 1D). As expected, the AKAP12 signals specifically
disappeared in the fibrotic scar of the AKAP12 KO mice (Fig. 1E).
These data show that AKAP12-positive cells are found in the
fibrotic scar.
AKAP12 KO mice showed leakage from the lesion with
abnormal morphology of the fibrotic scar
Photothrombosis induces thrombus in most blood vessels of the
illuminated lesion core (LC) [15,21] and it completely blocks the
circulation through the blood vessel (Supplementary Fig. 1A).
Thus, immediately after injury, immune cells only infiltrate
through the peri-lesion (PL) site not the LC site, resulting in
blood-brain barrier (BBB) breakage by inflammation that primar-
ily occurs at the PL site. Therefore, Evans blue extravasation in the
inflammation stage (PT1,PT3) was observed in the shape of a
ring with the lesion core as the center (Fig. 2A-WT group_ PT1
and PT3). This pattern of Evans blue extravasation disappeared
before reaching day 14 after injury (Fig. 2A-WT group_ PT7,
PT14 and PT21), implying that spontaneous recovery of impaired
BBB was primarily occurred during this period [22,23].
During the new tissue formation stage (PT14,PT21), infiltrat-
ing immune cells cause the lesion tissue to be destroyed by
phagocytosis, and the newly formed scar tissue separates the lesion
from normal tissue. Hoechst staining and differential interference
contrast (DIC) images in Supplementary Fig. 1B show that the cell
number and the density of lesion tissue are very low compared to
normal brain tissues at 21 days after injury, while many cells form
scar tissue with high density around the LC site. Therefore, Evans
blue dye in the cerebrospinal fluid (CSF) accumulated in the loose
lesion tissue without dispersing across the fibrotic scar (Fig. 2A-
WT_PT14, PT21, and Fig. S1C). Additionally, vessels were rarely
observed in the LC, showing that the accumulated dye in LC did
not result from BBB leakage generated by the newly formed vessels
(Fig. S1D). These results suggest that the fibrotic scar could
function as a barrier in the new tissue formation stage of repair
(PT14,PT21).
Likewise, BBB breakage (Evans blue extravasation shaped of
ring) seemed to have mainly recovered before reaching day 14
after injury in our injury model, and BBB breakage was not
observed near the lesion site on day 14 after injury, the time when
the fibrotic scar may begin to function as a barrier (Fig. 2A-WT
Figure 2. AKAP12 KO mice showed leakage from the lesion with abnormal morphology of the fibrotic scar. (A) Evans blue
extravasation assay. Significant differences between the WT and AKAP12 KO mice were observed from day 14 after injury. Scale bar: 2 mm (LC: lesion
core, PL: peri-lesion) (B) Evans blue was extracted from the brain tissue, and the amount of Evans blue was quantitatively analyzed by measuring the
OD (mean6 S.D.; n = 4 mice per WT and KO at each time point; P**,0.01, P#,0.001). (C) The lesion site of the WT mouse was tightly separated with
the normal tissue on day 14 and 21 after injury without any leakage. However, the AKAP12 KO mice showed an unclear boundary between the lesion
site and normal tissue with a dispersion of Evans blue. Scale bar: 1 mm.
doi:10.1371/journal.pone.0094695.g002
AKAP12 (+) Cells Mediate the Fibrotic Scar Barrier
PLOS ONE | www.plosone.org 4 April 2014 | Volume 9 | Issue 4 | e94695
group). Therefore, although the Evans blue permeability assay has
been used for the quantification of BBB breakage, in this
experiment, we can evaluate the barrier function of the fibrotic
scar from day 14 after injury using the assay.
As a result, there was no difference from day 1 to 7 after injury
between the WT and AKAP12 KO mice; however, significant
differences emerged from day 14 after injury (Fig. 2A). These
results correlate with the previous data (Fig. 1A and B) that the
Figure 3. AKAP12-positive cells form a structure to restrict immune cells in the fibrotic scar. (A) Mouse brains were harvested at serial
time points after photothrombotic injury. Brain sections were stained with antibodies for AKAP12 and GS-lectin (a marker for monocytes and
macrophages). Nuclei were stained with Hoechst. Scale bar: 20 mm (B) The structure formed by AKAP12-positive cells traps most types of immune
cells. Brain sections were stained with antibodies for AKAP12, CD3 (a marker for T cells), MPO (a maker for neutrophils), and IBA1 (a marker for
monocytes and macrophages) and GS-lectin (a marker for monocytes, macrophages). Scale bar: 20 mm (C) Mouse brains were harvested at 21 days
after photothrombotic injury. AKAP12-positive cells in the fibrotic scar expressed Occludin, E-cadherin and ZO-1 which permit their function as a
physical barrier. Scale bar: 40 um. (D) Brain sections were triple-stained with antibodies for AKAP12, GS-lectin and Occludin. Scale bar: 20 mm.
doi:10.1371/journal.pone.0094695.g003
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Figure 4. AKAP12 KO mice showed an impaired fibrotic scar structure with loss of junction complexes. (A) The structure of the scar
tissue was unstable in the AKAP12 KO mice (a/d). More IBA1-positive immune cells infiltrated across the fibrotic scar in the AKAP12 KO mice (b/e).
AKAP12 KO mice showed much more hypertrophic GFAP-positive astrocytes and IBA1-positive microglial cells near the fibrotic scar (c/f). Scale bar:
200 mm (left panel), 40 mm (right panel) (B) The expression of junction proteins in the fibrotic scar was reduced in the AKAP12 KO mice compared to
the WT mice on day 21 after injury. Brain sections were stained with antibodies against ZO-1, Occludin, and E-cadherin. The lower three columns are
magnified images of the fibrotic scar. Scale bar: 200 mm (upper panel), 40 mm (lower panel) (C) The experimental condition was same for panel b. For
each marker, the immunoflouresence intensity of three representative slides per mouse were analyzed using Image J. (Mean 6 S.D.; n = 4 mice per
each time; P#,0.001) (D) The global level of junction proteins were decreased in the AKAP12 KO mice. The lesion tissues were harvested from the
brains of mice on day 21 after injury and the tissue lysates were analyzed by Western blot (Mean 6 S.D.; n = 4 mice per WT and KO; P*,0.05, P**,
0.01). [LC: lesion core, FS: fibrotic scar, GS: glial scar].
doi:10.1371/journal.pone.0094695.g004
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AKAP12 level significantly increased from day 14 after injury.
Extravasation of Evans blue into the brain tissue of the AKAP12
KO mice was quantitatively increased 1.9 fold on day 14 and 6.9
fold on day 21 compared to the WT mice (Fig. 2B). While the
lesion site of the WT mice was tightly separated with normal tissue
by a solid structure on day 14 and 21 after injury, the AKAP12
KO mice showed an unclear boundary between the lesion site and
the normal tissue with a dispersion of Evans blue near the lesion
site (Fig. 2C). These data suggest that AKAP12 KO mice may
have an impaired fibrotic scar that allows the dispersion of Evans
blue dye.
AKAP12-positive cells form a structure that restricts
immune cells in the fibrotic scar
Interestingly, the structure formed by AKAP12-positve cells was
not just a simple layer made by cell adhesion. Through histological
analysis at serial time points after photothrombotic injury, we
found that AKAP12-positve cells form the structure trapping
immune cells in the fibrotic scar.
On day 7 after injury, pseudomorphous AKAP12-positive cells
were embedded among numerous immune cells infiltrated into the
lesion site, and the cells linked to each other around the immune
cells over time. On day 14 after injury, the AKAP12-positive cells
formed an interesting structure, shaped like a sponge, trapping
immune cells. Thereafter, the cells attached to each other
eliminating the immune cells and finally formed a thick layer
(Fig. 3A). A lot of phagocytic monocytes and macrophages along
with a few T cells and neutrophils were observed in the fibrotic
scar on day 21 after injury, and most types of immune cells were
trapped in the structure formed by the AKAP12-positive cells
(Fig. 3B). To confirm that the immune cell- trapping structure by
AKAP12-positive cells is also formed in another injury model, we
utilized the rat middle cerebral artery occlusion (MCAO) model
and found the formation of a similar structure on day 21 after
injury. The AKAP12-positive cells formed an immune cells-
trapping structure in the lesion near the meninges (Fig. S2_a, b).
However, this structure was not observed deep inside the MCAO
lesion (data not shown). It is thought that there are some
differences for more widespread infarct size in MCAO compared
to PT. These results suggest that our findings are not an artifact of
the photothrombosis model, and that AKAP12-positive cells could
be involved in a meningeal response to injury.
Tight junction and adhesion proteins like Occludin, ZO-1 and
E-cadherin are known to be essential for the maintenance of
various biological structures by connecting between associated
cells, and allow for the function of a physical barrier by blocking
the flow of substances [24,25,26]. Interestingly, the AKAP12-
positive cells, which form the structure trapping the immune cells,
strongly expressed such tight junction and adhesion proteins
(Fig. 3C). Collectively, triple staining data in Fig. 3D show that
Figure 5. AKAP12 KO mice showed larger demyelinated and infarcted tissue compared to WT from the extended infiltration of
immune cells. (A) The areas infiltrated by CD45-positive leukocytes increased in the AKAP12 KO mice on day 21 after injury. Brain sections were co-
stained with antibodies against fibronectin and CD45 (the marker for pan leukocytes). Scale bar: 500 mm (left panel), 200 mm (magnified panel) (FS:
fibrotic scar) (B) The AKAP12 KO mice showed more severe inflammation compared to the WT mice. The areas infiltrated by the IBA1-positive immune
cells and the number of IBA1-positive cells per unit area near the lesion site increased in the AKAP12 KO mice on day 21 after injury (mean 6 S.D.;
n = 6 mice per WT and KO and 3 positions per mouse; P#,0.001). Scale bar: 200 mm (C) The AKAP12 KO mice showed increased demyelination
compared to the WT. Luxol fast blue (LFB) staining was performed to evaluate demyelination (the asterisk region) in the injured brain (mean 6 S.D.;
n = 4 mice per WT and KO; P**,0.01). Scale bar: 2 mm (D) The AKAP12 KO mice showed increased tissue damage compared to the WT.
Triphenyltetrazolium chloride (TTC) staining to evaluate the infarct volume (Mean 6 S.D.; n = 4 mice per WT and KO; P#,0.001). Scale bar: 2 mm.
doi:10.1371/journal.pone.0094695.g005
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AKAP12-positive cells formed structures by connecting to each
other through the tight junction protein Occludin, following
which, GS lectin-positive immune cells became embedded in the
structure. For these properties of the AKAP12-positive cells such
as tightly enclosing the immune cells and highly expressing tight
junction proteins, the structure formed by the AKAP12-positive
cells is expected to function as a barrier to restrict inflammation in
the fibrotic scar.
AKAP12 KO mice showed an impaired fibrotic scar
structure with loss of junction complexes
To validate the function of the AKAP12-positive cells in the
fibrotic scar in vivo, histological differences in the fibrotic scar were
compared between WT and AKAP12 KO mice after photo-
thrombotic brain injury. The fibronectin staining data reveals that
the scar structure of the AKAP12 KO mice was loosely assembled
on day 21 after injury (Fig. 4A a/d). Consequently, more IBA1-
positive immune cells infiltrated into the parenchymal tissues
across the fibrotic scar (Fig. 4A b/e). Furthermore, IBA1-positive
resident microglia and GFAP-positive astrocytes near the fibrotic
scar in the AKAP12 KO mice showed a hypertrophic morphology
(Fig. 4A c/f), implying that inflammatory materials were
discharged from the fibrotic scar. Immunostaining data shows
that the expressions of ZO-1, Occludin and E-cadherin were
significantly reduced in the fibrotic scar of the AKAP12 KO mice
compared to the WT mice (Fig. 4B and C).When we analyzed
lysates from the lesion tissues harvested as described in Fig. S3, the
results of western blot revealed reduced levels of junction proteins
in the lesion tissue of the AKAP12 KO mice similar to the result of
immunostaining data, (Fig. 4D). These data suggest that AKAP12
is crucial for maintaining the junction complex of the cells which
form scar barrier; and such breakage of the junction complex
explains well the impaired scar structure (Fig. 4A a/d) and the scar
barrier not functioning in the AKAP12 KO mice (Fig. 2C).
AKAP12 KO mice showed extended immune cell
infiltration and tissue damage compared to the WT
To confirm whether AKAP12-regulated pathways are beneficial
during the recovery phase after brain injury, the extent of immune
cell infiltration and tissue damage were compared between the
WT and AKAP12 KO mice. As shown in Fig. 5A, while most
CD45-positive immune cells were restricted within the fibrotic scar
in the WT mice, many more immune cells spread further into the
neural parenchyma in the AKAP12 KO mice across the fibrotic
scar. Moreover, many more cells, which express IBA1, a marker
for macrophage and microglia, were observed near the lesion site
of the AKAP12 KO mice compared to the WT mice (Fig. 5B).
To compare the degree of inflammation near the scar, we
counted only spherical cells excluding inactive microglia which
have a ramified form among the IBA1-positive cells. The total
number per unit (1 mm2) of IBA1-positive cells near the lesion site
increased 2.2 fold in the AKAP12 KO mice compared to the WT
mice on day 21 after injury [WT: 32656424, AKAP12 KO mice:
71536677] (Fig. 5B graph), implying that inflammation is more
severe in the AKAP12 KO mice. Interestingly, the immune cell
population, which has a small size, was much higher in the
AKAP12 KO mice relative to the WT mice, implying the
possibility that new immune cells continue to infiltrate across the
scar barrier. Because severe inflammation could lead to extended
tissue damage in the CNS, we compared tissue damage between
the WT and AKAP12 KO mice on day 21 after injury by
measuring demyelination and infarct size. The extent of demye-
lination was evaluated with Luxol fast blue (LFB) staining. The
proportion of LFB-negative regions to the total brain increased 2.1
fold in the AKAP12 KO mice [WT: 1.0560.18%, AKAP12 KO:
2.2260.37%] (Fig. 5C). Finally, the extent of infarct size was
evaluated with triphenyltetrazolium chloride (TTC) staining. The
ratio of TTC-negative regions to the total brain increased 2.3 fold
in the AKAP12 KO mice compared to the WT mice on day 21
after injury [WT: 0.9060.05%, AKAP12 KO: 2.0660.12%]
(Fig. 5D). These results strongly suggest that AKAP12 is important
in the formation and maintenance of the scar barrier, which acts as
a potentially protective physical barrier during recovery after brain
injury.
Discussion
There have been experimental limitations in verifying the in vivo
function of the fibrotic scar using conditional KO mice due to the
absence of information about the exact cell types comprising the
fibrotic scar and their marker proteins. Therefore, previous studies
on CNS scars primarily concentrated on the glial scar composed of
astrocytes which has specific marker proteins like GFAP [27,28].
However, through recent studies, meningeal cells [5] and pericytes
[10] were identified as cell types found in the fibrotic scar, and it
has been suggested that the fibrotic scar also has important roles in
CNS repair, and it could be a potent target for therapeutics [9,29].
Therefore, it is expected that the fibrotic scar will become a subject
of great interest in the field of CNS repair.
Although the function of the fibrotic scar was reported to be
harmful as an obstacle for axonal regeneration in the remodeling
stage of repair [8], all three stages of repair, inflammation, new
tissue formation, and tissue remodeling, have shown both
detrimental and beneficial effects [6,30]. Furthermore, the fibrotic
scar is a complex structure comprised of multiple cell types which
have different properties [5,10]; therefore, it could be multi-
functional depending on the stage of CNS repair. From this
viewpoint, our findings suggest the possibility that the fibrotic scar
has beneficial roles in the new tissue formation stage of repair,
which are mediated by AKAP12-positive cells.
Based on the serial observations in our injury model, the
proportion of AKAP12-positive cells in the fibrotic scar increased
over time, and they finally formed the structure trapping the
immune cells infiltrated into the lesion site by linking to each
other. Interestingly, the AKAP12-positive cells highly expressed
junction and adhesion proteins like Occludin, ZO-1, and E-
cadherin. These proteins are known to be essential for the barrier
function of biological structures including the BBB and the
epithelium by making junction complexes which provide strong
tightness between cells. Therefore, it is expected that the AKAP12-
positive cells did not simply encircle immune cells but restrict them
from the normal parenchymal tissue. Our in vivo validation data
strongly support this possibility by showing extended inflammation
and tissue damage with the loss of the junction complex in the
fibrotic scar of the AKAP12 KO mice. These new findings show
the mechanisms that underlie the beneficial actions of the fibrotic
scar in the new tissue formation stage of the CNS repair process.
Additionally, Occludin, ZO-1, and E-cadherin, expressed by
AKAP12-positive cells are also known as the most well-known
makers for epithelial cells and the AKAP12 KO mice showed a
reduced level of these junction proteins in the fibrotic scar.
Furthermore, we observed that the AKAP12 knock-down
decreased the junction proteins in several epithelial cell lines (data
not shown). These data imply that the origin of the AKAP12-
positive cells could be cells with epithelial properties and AKAP12
is expected to be crucial for maintaining epithelial properties by
regulating the expression of junction proteins.
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Meanwhile, inflammation, gliosis, scar formation after brain
injury and neurodegeneration are complex multiphasic processes
[30], and we used the general KO system for in vivo validation of
AKAP12. Therefore, it must be acknowledged that various cells
such as endothelial cells, meningeal cells, astrocytes, microglia, and
pericytes may also play some roles in the effects observed in the
AKAP12 KO. Particularly, we have reported that AKAP12
regulates vessel integrity and BBB formation during the develop-
ment of zebrafish and mouse, respectively [31,32]. However, there
seems to be differences in the function of AKAP12 between
development and adult pathophysiological conditions. In contrast
to the zebrafish embryo, the expression of AKAP12 was very low
in the endothelial cells (ECs) of adult mouse brain vessels (Fig. 6
panel a and b), and scarcely changed in the ECs until day 21 after
injury (Fig. 6 panel c) Normal astrocytes wrapping vessels in the
BBB structure also hardly expressed AKAP12 in the normal adult
mouse brain (Fig. 6 panel d). Although the expression of AKAP12
was slightly increased in activated astrocytes to form the glial scar
near the lesion site, it was insignificant compared to that of the
cells to form the fibrotic scar (Fig. 6 panel e). In our model, the
leakage of microvessels primarily peaked on day 3 after injury, and
gradually recovered until day 7 after injury (Fig. 2A: Evans blue
extravasation assay). If AKA12 functions in vessel integrity and the
BBB, there have to be differences in the microvessel leakage
Figure 6. The expression of AKAP12 is very low in the endothelial cells and astrocytes of the adult mouse brain. The mouse brain was
extracted on day 21 after injury, and brain sections were stained with antibodies for AKAP12, GFAP (the marker for astrocyte) and CD31 (the marker
for endothelial cell). Nuclei were counterstained with Hoechst 33342. AKAP12 was little expressed in the endothelial cells of vessels in normal
meninges (panel a) and cortex (panel b). Endothelial cells of vessels in the fibrotic scar also hardly expressed AKAP12 (panel c). AKAP12 level was very
low in normal astrocytes wrapping vessels (panel d). The expression of AKAP12 seems to be slightly increased in reactive astrocytes forming the glial
scar. However, it was insignificant compared to that of the meningeal cells (panel e). Scale bar: 50 mm (leftmost panels), 20 mm (panel a, b, d and e
have same magnification except panel c).
doi:10.1371/journal.pone.0094695.g006
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between WT and AKAP12 KO mice during this period. However,
differences were not observed in this period but from day 14 after
injury, the time when the fibrotic scar may begin to function as a
barrier. Moreover, it is expected that differences in vessel integrity
and BBB stability could affect the penumbra. However, the size of
the penumbra was also not changed by AKAP12 KO (Fig. S4),
consistent with the Evans blue extravasation assay. These data
suggest that the effect of the AKAP12 KO may primarily result
from a malfunction in the protective fibrotic scar rather than from
the loss of vessel integrity and BBB instability under adult
pathophysiological condition. However, since it cannot be
completely excluded that AKAP12 KO could affect vessel integrity
and BBB stability, further studies using an endothelial cell specific
AKAP12 KO system are needed to verify the possibility.
The fibrotic scar is expected to be the structure of versatility due
to different properties of each cell type forming the fibrotic scar. In
this respect, our results show that AKAP12-positive cells in the
fibrotic scar have the potential to isolate immune cells, implying
that the fibrotic scar could function as a physical barrier to restrict
inflammation. Together with previous studies reporting that the
fibrotic scar inhibits axonal regeneration during the stage of
remodeling, such findings provide an extended view that fibrotic
scar could have different functions depending on the stages of
CNS repair. Therefore, for targeting the fibrotic scar to promote
recovery after brain injury, coordinated approaches are necessary
to maintain the protective role of the fibrotic scar in the early stage
of repair and to block the destructive pathways that inhibit axonal
regeneration in the later stage of repair. Furthermore, follow-up
studies are warranted to determine how the protective AKAP12
mechanisms intersect with the destructive pathways such as those
involving inhibitory matrix molecules and to explore how these
mechanisms may be therapeutically targeted to promote repair
and recovery after brain injury.
Supporting Information
Figure S1 The histological characteristics of the lesion
core tissue. (A) 2% Evans blue saline solution (100 mL) was
injected via the tail vein at 3 days after photothrombotic injury.
After circulation for 2 h, the brains were extracted. The unstained
lesion core shows that photothrombosis completely blocks the
circulation through the blood vessel. Scale bar: 5 mm (B) Mouse
brains were harvested at 21 days after photothrombotic injury.
Brain sections were stained with Hoechst solution for nuclear
staining (pseudo-colored green). Scale bar: 500 mm (upper panel),
200 mm (magnified images) (C) Evans blue saline solution was
injected at 21 days after photothrombotic injury. Mice were
perfused after circulation for 2 h, and the brains were extracted.
The brain section shows that Evans blue dye was restricted within
the lesion core without dispersion across the scar tissue. Scale bar:
1 mm (D) Mouse brains were extracted on day 21 after injury, and
the brain sections were stained with antibodies for CD31 (the
marker for endothelial cell). Vessels were rarely observed in the
lesion core where the dye accumulated. Scale bar: 500 mm [N:
normal tissue, LC: lesion core, FS: fibrotic scar)].
(TIF)
Figure S2 AKAP12-positive cells formed immune cell
trapping structures in rodent middle cerebral artery
occlusion (MCAO) injury models. The structure formed by
AKAP12-positive cells is also observed in rodent middle cerebral
artery occlusion (MCAO) injury models. Rat brains were
harvested on day 21 after MCAO injury. [a] is the boundary of
the lesion site and [b] is the fibrotic scar. Scale bar: 200 mm (left
panel), 40 mm (magnified right panel), 40 mm (lower panel).
(TIF)
Figure S3 The method to define and collect the lesion
tissue. (A) After perfusion, the lesion site was easily distinguish-
able from the normal tissue. Injured mouse brains were coronal-
dissected at the inside from the lesion boundary with a razor blade
in a mold. Scale bar: 1 cm, 1 mm (magnified image) (B) Since the
scar tissue is white compared to adjacent tissues due to its high cell
density, the scar tissue becomes the border line between the
normal and the lesion tissue. To harvest both the lesion and scar
tissue, brain coronal sections were dissected with a razor blade in
three directions along the outside of the scar tissue. Scale bar:
1 mm.
(TIF)
Figure S4 AKAP12 KO did not affect to the penumbra.
Mouse brains were extracted at 1 day after injury, and serial brain
slices (2 mm thickness) near the lesion site were incubated for
30 min at 37uC in 0.05% TTC solution. Pictures of the brain slices
were taken after fixation with 4% PFA and analyzed using Image J
program. (Mean 6 S.D.; n= 4 mice per WT and KO; an
unpaired two-tailed Student t-test: NS: not significant) Scale bar:
2 mm.
(TIF)
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